A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Primary Membranous Nephropathy
Interventions
DRUG

B007

B007: Subcutaneous injection was administered on days 1 and 15

DRUG

Cyclosporin Capsules

Cyclosporin Capsules: Orally, 3.5 mg/kg/d;

Trial Locations (21)

Unknown

RECRUITING

Beijing Tsinghua Changgung Hospital, Beijing

RECRUITING

Peking university first hospital, Beijing

RECRUITING

The Second Norman Bethune Hospital of Jilin University, Changchun

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine, Hangzhou

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

RECRUITING

Affiliated Hospital of Nantong University, Nantong

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

Northern Theater Command General Hospital, Shenyang

RECRUITING

Shengjing Hospital affiliated to China Medical University, Shenyang

RECRUITING

Peking University Shenzhen Hospital, Shenzhen

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

RECRUITING

Wuxi People's Hospital, Wuxi

RECRUITING

Xi'an Daxing Hospital, Xi'an

RECRUITING

The Second Affiliated Hospital of Xingtai Medical college, Xingtai

RECRUITING

Northern Jiangsu People's Hospital, Yangzhou

RECRUITING

Yantai Yuhuangding Hospital, Yantai

RECRUITING

The First People's Hospital of Zigong, Zigong

All Listed Sponsors
collaborator

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

lead

Shanghai Jiaolian Drug Research and Development Co., Ltd

INDUSTRY